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Abstract 
We analysed the expression of protein kinase C (PKC) isoforms in smooth muscle cells (SMC) in various states of differentiation, using Western 
blots and thermocycle amplification of mRNA. SMC isolated from intact tissues express three isoforms of PKC, namely a, 6, and c. Following cell 
culture, SMC additionally express mRNA for PKC-E, but significant amounts of the corresponding protein were not detected. Transformed SMC, 
such as the cell line DDT, MF-2, express both mRNA and protein for PKC-E, lack the 6 isoenyzme, whilst maintaining the expression of the a and 
< isoforms. Thus PKCd and E isoenzyme xpression appears to vary with the state of differentiation of these cells, with PKC-E expression increasing 
as the cells become proliferative. 
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1. Introduction 
Extracellular signals can activate the phospholipid- 
dependent protein kinase C (PKC) by phospholipase C 
(PLC)-derived sn- 1 ,Zdiacylglycerol (DAG), by DAG 
derived from phosphatidylcholine via the actions of 
phosholipase D and phosphatidic acid phosphohydro- 
lase, by arachidonic acid and by unsaturated fatty acids 
[l]. PKC also acts as the cellular receptor for the tumour 
promoting phorbol esters [2]. 
There are at least 8 distinct isoforms of this enzyme, 
which can be divided into two classes; the classical, cal- 
cium-dependent isoforms (a, /? and y), and calcium-inde- 
pendent forms (6, E, q and 0 [3,4]. All PKC isoforms 
are present in the brain, whereas other tissues appear to 
express a limited repertoire, with certain isoforms more 
widely distributed than others [4,5]. Although the 
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isoforms appear to be associated with different functions 
[6,7], their roles in specific cells have yet to be deter- 
mined. 
Smooth muscle cell (SMC) proliferation is clinically 
important in e.g. atherosclerosis, angioplasty, re-stenosis 
and vein graft occlusion. According to the ‘response to 
injury’ hypothesis [S] this proliferation is the result of 
locally released growth factors. Growth factors bind to 
cell surface receptors, leading to tyrosine kinase activa- 
tion, receptor autophosphorylation and activation of a 
kinase cascade thought to involve Ras protein, Raf-1, 
mitogen-activated protein (MAP) kinase kinase and 
MAP kinase [9,10]. Stimulation of G-protein coupled 
receptors, e.g. by serotonin or endothelin, can also lead 
to proliferation [l 11. The mechanism is less clear, but 
may involve PKC. Proliferating cells exhibit greater 
PKC activity than quiescent cells, and more of the is 
enzyme associated with the particulate fraction [12]. 
Also, direct activation of PKC by phorbol esters may 
induce SMC proliferation, whilst inhibition of PKC by 
selective inhibitors can inhibit it [13]. 
Previous observations uggested that SMC express at 
least 2 isoforms of PKC [14], and that these may have 
distinct functions with regard to regulating SMC prolif- 
eration [15]. Since the state of differentiation of SMC is 
altered in the neointimal thickenings of injured or ath- 
erosclerotic arteries compared to those in the quiescent, 
contractile artery, we studied PKC isoform expression in 
cells from various sources. The results suggest that PKC 
expression depends on SMC differentiation. 
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2. Materials and methods supematant removed and the proteins were acetone precipitated (the 
‘cytosolic’ fraction). The membrane pellet was resuspended in lysis 
buffer containing 0.1% Triton X-100 (400 ul) and vortex mixed for 
30 min. Centrifugation (12,000 x g, 10 t&n) yielded a supematant con- 
taining the ‘membrane fraction’ and a pellet referred to as the ‘urea 
fraction’. This pellet was vortexed with 8 M urea in 10% SDS, for 20 
mitt, centrifuged (12,000 x g, 10 mm), and the supematant remaining 
was acetone precipitated. Proteins in the ‘membrane fraction’ were also 
acetone precipitated overnight at -20°C. The protein was collected by 
centrifugation (12,000 x g, 15 min), resuspended inLaemmli buffer and 
the samples run on SDS-PAGE and blotted as described above. 
2.1. Materials 
Cultured human renal artery SMC were a gift from Dr. J. Nilsson 
at the vascular cell biology group at the Karolinska Hospital, Stock- 
holm. DDT, MF-2 SMC derived from steroid-induced leiomyosarcoma 
of Syrian hamster vas deferens [16], were purchased from ATCC. 
Human saphenous vein was obtained from the Dept. Cardiology, Car- 
diff. Rat vas deferens were freshly dissected out. Antibodies to PKC a, 
/3., B,, &i, y and E and the corresponding purified enzymes were kindly 
provided by Prof. Nishizuka, Kobe University, Japan; antibodies to 
PKC S, E and c and corresponding peptides were purchased from Gibco 
(BRL, Grand Island, NY, USA). All the antibodies were raised against 
the CKpV, region except hose to y (CKpV,) and to the common region 
of the/J isofonns ds,, CKpV,). Molecular biology reagents were either 
from Promega (Scandinavian Diagnostic Services (SDS), Falkenberg, 
Sweden) or Pharmacia-LKB (Uppsala, Sweden). 
2.2. SMC Culture 
SMC were cultured in Dulbecco’s modification of Eagle’s medium 
(DMEM) supplemented with penicillin/streptomycin, L-glutamine and 
fetal calf serum (FCS, lo%), in a humidified 5% COj95S 0, atmos- 
phere, at 37°C. Cells were passaged using trypsin (0.05%)-EDTA 
(0.02% w/v in normal saline) as required and batches frozen in liquid 
nitrogen. Two time-points for analysis were selected - namely after 
passage 6-S or after passage 27-30 - to differentiate between cell pop- 
ulations containing some ‘reversibly’ synthetic ells, and SMC selected 
by multiple passage for their synthetic ability. All cell populations were 
confirmed to be pure cultures of SMC by positive staining with a 
monoclonal antibody to a-SMC actin (Clone lA4, Sigma). 
DDT, MF-2 cells were cultured under similar conditions except hat 
only 5% FCS was required. 
2.3. Protein analysis by Western blotting 
SMC (5 x 1 O5 cells) were plated onto 10 mm diameter Petri dishes and 
grown for 2 days. Cellular protein was extracted by washing the cells 
with phosphate-buffered saline (PBS) and then treating with 1.5 ml of 
lysis buffer (20 mM Tris-HCl, pH 7.5, 2 mM EDTA, 10 mM EGTA, 
1 mM dithiothreitol, 1 mM phenylmethanesulfonyl fluoride) supple- 
mented with 0.05 mg/ml digitonin, 0.1% Triton X-100, 10 &ml 
leupeptin and 10 pg/mI pepstatin A. After 5 min on ice, the cells were 
scraped into Eppendorff tubes and vortexed (30 min, 4°C). The super- 
natant after centifugation (12,000 x g, 15 min) was acetone precipitated 
at -20°C overnight. The resulting protein pellet was resuspended in 
Laemmli sample buffer, boiled for 5 min and then run on an 8% 
polyacrylamide, denaturing gel. 
DDT, MF-2 cells (lo6 cells/sample) were pelleted by centrifugation 
(5,000 x g, 5 min), washed in PBS, resuspended in lysis buffer and 
proteins extracted as above. Protein from intact vessels was prepared 
by crushing the vessel under liquid nitrogen and then rapidly resuspend- 
ing the powder in boiling Laemmli sample buffer. Rat brain cortex and 
vas deferens were homogenized in lysis buffer and then sonicated for 
2 min. The supematant after centrifugation (1 h, 100,000 x g, 4°C) was 
acetone precipitated, resuspended in Laemmli buffer and electrophore- 
sed, as above. 
Proteins were blotted onto a membrane (Immobilon, Millipore, 
Bedford, MA, USA) and non-specific binding blocked by an overnight 
incubation in Tris-buffered saline (TBS; Tris-HCl, pH 7.6, 500 mM 
NaCl) containing Tween-20 (0.5%) and 5% FCS. Membranes were 
incubated with PKC-specific antibodies for 3 h, before washing 3 x 10 
min with TBS-Tween. Antibody binding was detected with a second 
antibody (horseradish peroxidase conjugated anti-rabbit), and an en- 
hanced chemiluminescence system (Amersham, GB). Specificity of the 
primary antibody binding was checked by preincubation of the anti- 
body with isoform-specific peptide (0.5 mg/ml) or purified enzyme 
(2 &ml) for 10 min at room temperature prior to use. 
2.4. TPA treatment and cell fractionation 
SMC were grown in Petri dishes as above, but prior to protein 
extraction, the cells were washed with DMEM containing 20 mM 
HEPES and then reacted with 12-O-tetradecanyl-phorbol 13-acetate 
(TPA, 100 nM) for 10 min, 37°C. The cells were then washed with PBS 
and treated with lysis buffer supplemented as above but lacking Triton 
X-100. The protein suspension was centrifuged (12,000 x g, lOmin), the 
2.5. Thermocycle analysis of mRNA 
Cytoplasmic RNA from either SMC, DDT, MF-2 cells or cerebel- 
lum, was prepared using a ‘mini-prep’ method [17] and messenger 
(m)RNA selected using an oligo d(T) column. Vascular tissue was 
crushed under liquid nitrogen, resuspended in Solution D (4 M gua- 
nidium thiocyanate, 25 mM sodium citrate, pH 7.0, 0.5% sarcosyl, 
100 mM /I-mercaptoethanol), DNA sheared through a needle, and the 
RNA was phenol/chloroform extracted. Remaining DNA contamina- 
tion was removed by DNAase digestion (37°C 40 min) and mRNA 
selected using an oligo d(T) column. Vas deferens was crushed under 
liquid nitrogen and mRNA extracted using the PolyAT tract system 
1000 (Promega, SDS, Sweden). 
cDNA was produced from approximately 0.06 fig mRNA, using 
Moloney murine leukemia virus reverse transcriptase (Gibco-BRL) 10 
units, 40°C for 50 min, in a buffer containing 6.9 mM MgCl,, 50 mM 
KCl, 10 mM Tris-HCl pH 9.0,0.1% Triton X-100,4 mM dNTP, 1 unit 
rRNasin ribonuclease inhibitor, 19pM pd(N), random hexamers, final 
volume 20 ~1. This cDNA was then analysed by thermocycle amplifica- 
tion of sequences pecific for the various isoforms of PKC. The se- 
quences amplified were based on ones previously selected by Freire- 
Moar et al. [18] i.e. those sequences between base pairs 875-l 199 for 
a,925-1188for~,713-1257fory,1013-1364for6,577-1308for~,and 
4041085 for c. Amplification of 10~1 cDNA was performed with 0.025 
units Thermus aquaticus Taq DNA polymerase in 10 mM Tris-HCl, 
DH 9.0. 50 mM KCl. 0.1% Triton X-100. 5.4 mM MeCl,. 0.9 mM 
hNTP,‘and 2.8 pg of’each primer, final volume 50 ,ul. FKC isoforms 
a and 6 were run on a thermoamplification program consisting of an 
initial denaturation at 94°C 5 min, followed by 35 cycles of 1 min 
denaturation (92”C), 2 min annealing (55°C) and 2 min elongation 
(72°C) with a final extension period of 5 min at 72°C. The longer 
products (y, E and 0 were run on the same program except that the 
length of the elongation period was increased to 3 min. The /3 isoform 
however required a different protocol: 1 min denaturation (94”C), 14 
cycles of 1 min 95”C, 2 min 55”C, 1 min 72°C then 19 cycles of 1 min 
95°C 2 min 55°C 3 min 72 “C, followed by 5 min at 72°C. Products 
were run though a 2% agarose gel, containing 3% (v/v) ethidium bro- 
mide and detected by trans-illumination with UV light. 
3. Results and discussion 
Western blot analysis demonstrated the presence of 
three isoforms of PKC in SMC, namely PKC-(r, 6 and 
trace amounts of 5 (Fig. 1). Rat brain protein was run 
as a positive control and clearly shows that under the 
conditions employed all 7 isoforms of PKC studied could 
be detected (Fig. 1). The molecular weights of these pro- 
teins were consistent with previously published findings 
[3,5,19]. As further confirmation that the proteins de- 
tected were PKC, the primary antibody was preincu- 
bated with the corresponding purified enzyme or with 
the peptide against which the antibody was raised, and 
this was shown to prevent protein detection (Fig. 2). 
The type III enzyme previously described [14] as hav- 
ing both proliferative and anti-proliferative actions in 
SMC, was probably PKC-a. Consistent with the earlier 
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Fig. 1. Protein kinase C @KC) isoform expression examined by Western blot. Smooth muscle cell (S) protein was compared with a rat brain (B) 
positive control. 
observations, we found it to be readily down-regulated 
by long-term treatment with phorbol ester (Fig. 2). 
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Fig. 2. Activation and translocation of protein kinase C (PKC) by 
phorbol ester (TPA). (Upper panel) PKC-cl detected in rat brain posi- 
tive control (+), blocked by preincubation of the antibody with PKC-a 
peptide (-1, and in smooth muscle cells iysed to produce cytosolic (c), 
m~brane (m) and urea extractable (u) fractions. Upon stimulation 
with TPA (100 nM, 10 min) PKC-a was lost from the c fraction. (Lower 
panel) PKC-6 detection in fractionated unstimulated smooth muscle 
cells (control) or following TPA stimulation. Preincubation of the anti- 
body with 6 peptide greatly reduced the signal detected in all fractions. 
PKC-S appeared to be present in abundance in SMC, 
with a large proportion of this isoform associated with 
the membrane fraction even in unstimulated cells. The 
tight nature of this association, possibly involving inter- 
gration into a membrane, was illustrated by the finding 
that treatment with 8 M urea was required to fully disso- 
ciate it. Treatment of the cells with TPA for 10 min, lead 
to a further translocation of PKC-6 to the membrane 
fraction (Fig. 2). 
Thermocycle analysis of cultured SMC mRNA con- 
firmed that these cells express PKC isoforms a and 6, but 
in additon, PKC-E was also clearly detected (Fig. 3). In 
the absence of either mRNA or of reverse transcriptase 
enzyme no band was detected, indicating that the sam- 
ples were not contaminated with exogenous or en- 
dogenous DNA. Isoform expression appeared to be the 
same in both early (68th) and late (27-30th) passage 
SMC (Fig. 4). Comparison with the protein analysis, 
suggests that mRNA for PKC-6 is expressed in cultured 
SMC without significant translation into protein. Lack 
of antibody i~unoreactivity to the human sequence is 
unlikely to account for the lack of E protein detection, 
since E protein also could not be detected even in rabbit 
aorta, despite rabbit being a species to which the anti- 
body is known to react. In addition, neither the Ni- 
shizuka nor the Gibco antibody detected the protein, 
despite reacting to slightly different epitopes. 
Little if any mRNA for PKC-6 could be detected in 
cultured SMC. This was perhaps due to the fact that 
prior to RNA extraction the cells were grown to conflu- 
ency and had began to quiesce. If mRNA was extracted 
from SMC which were actively proliferating, some 
PKC-C could be detected (data not shown). The absence 
of isoforms B and y from these cells was confirmed by 
both Western blot and molecular analysis; the enzyme 
could not be detected using conditions which allowed the 
detection of a positive (brain) control. This pattern of 
isoform expression is again consistent with that previ- 
ously reported [14] for SMC. In addition, renal me- 
sangial cells have been found to express only PKC-a, 6, 
E: and c [20], consistent with the great similarity known 
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Fig. 3. Molecular analysis of protein kinase C (PKC) isoforms in smooth muscle cells (S). Rat cerebellum (B) was used as a positive control, RNA 
minus the reverse transcriptase nzyme or reaction mix minus RNA was run as a negative control (-). 
to exist between these cell types. In contrast, cardiac 
myocytes express PKC-jI [21], a difference possibly re- 
lated to the differences in signalling pathways seen be- 
tween these cells. Lack of PKC-r expression was ex- 
pected since this isoform is mainly located in neuronal 
tissues, although it has been reported to be present in 
some leukemic and glioblastoma cell lines [22,23]. 
Contractile SMC from intact vessels (human saphe- 
nous vein and rabbit aorta) were analysed and showed 
a similar pattern of protein staining to cultured SMC, i.e. 
isoforms a, 6 and some 6 could be detected (Fig. 5.1). 
Analysis of mRNA showed that, unlike their proliferat- 
ing counterparts, contractile SMC do not express PIE-& 
mRNA (Fig. 4). Next, cells of the smooth muscle tumour 
cell line DDT, MF-2 were studied. PKC-a was expressed 
together with significant amounts of P&X-c. PKC-6 was 
absent; however, PKC-s could be detected both by West- 
em blotting (Fig. 5.3) and by molecular analysis (Fig. 4). 
To test the trivial explanation that DDT, MF-2 cells are 
derived from vas deferens rather than vascular tissue, 
PKC expression in freshly isolated vas deferens was ex- 
amined. However, the pattern of PKC expression was 
the same as in blood vessels, with mRNA and protein 
detectable for PKC-a, 6 and 6, but not for E (Fig. 5.2 and 
6). The results therefore suggest that PKC-J and -E ex- 
pression alters with the state of differentiation of SMC, 
not their source: no e-isoform was detected in contractile 
cells. mRNA was expressed in cultured SMC but not 
translated to protein, whilst transformed SMC both 
transcribe and translate PKC-E. 
PKC-a, was expressed in SMC in all states of differen- 
tiation, consistent with the belief that this ubiquitous 
isoform serves a general role in cell physiology. It is 
interesting to note that despite the observed modification 
in &-isoform expression, SMC always expressed both a 
calcium-dependent and a calcium-independent isoform 
of PKC. Further it is interesting to speculate on the role 
of PKC-6. The tight association with the membrane frac- 
-+VAELD-+VA ELD -+V AE LD -+ VAEL D 
a ti E: i 
Fig. 4. Investigation of protein kinase C isoform expression by smooth muscle cells (SMC) in various states of differentiation. Samples were analysed 
by thermocycle ampliiication. A cerebellum positive (+) control and a negative (-) minus RNA or minus reverse transcriptase control was run. 
Contractile SMC from human saphenous vein (V) or rabbit aorta (A) were compared with cultured SMC from early (E, 68th) or late (L, 27-30th) 
passage, and with a SMC line DDT, MF-2 cells (D). 
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Fig. 5. Western blot analysis of protein kinase C isoenzyme expression 
in different tissues. (1) Comparison of human saphenous vein (V), 
rabbit aorta (A) and cerebellum positive control (B). (2) Intact vas 
deferens (VD). (3) Cultured vascular SMC (S) and the vas deferens 
derived tumour SMC line DDT, MF-2 cells (D). 
tion and its expression in contractile state cells, may 
indicate a role in cell contractility. In addition, PKC-6 
has previously been shown to inhibit cell-cycle progres- 
sion by blocking cytokinesis [24] indicating a possible 
role for this isoform in SMC growth inhibition. 
In conclusion, we have demonstrated the presence of 
four isoforms of PKC in SMC. PKC-a is generally ex- 
- + SVD - + VD - + VD -+ SVD 
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Fig. 6. Expression of protein kinase C (PKC) isoform mRNA in vas 
deferens. A cerebellum positive control (+), mRNA from cultured SMC 
(S) and from intact vas deferens (VD) were run. Lack of RNA or reverse 
transcriptase enzyme was used as a negative control (-). 
pressed as is PKC-5. The 6 isoform is found in intact 
vessels and cultured cells but is lost from cells during 
transformation. The expression of PKC-E appears to in- 
crease with the state of dedifferentiation of the cells, in 
accordance with the observation [25] that down-regula- 
tion of PKC-& promotes neuroblastoma cell differentia- 
tion. 
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